Horizon Pharma plc Announces Topline Results from Phase 3 Study of ACTIMMUNE® (interferon gamma-1b) in Friedreich’s Ataxia
I had so many hopes on this …
http://ir.horizon-pharma.com/releasedetail.cfm?ReleaseID=1003338
Horizon Pharma plc Announces Topline Results from Phase 3 Study of ACTIMMUNE® (interferon gamma-1b) in Friedreich’s Ataxia
I had so many hopes on this …
http://ir.horizon-pharma.com/releasedetail.cfm?ReleaseID=1003338
Thanks there is nothing in short future